Here are four key points:
1. From 2016 to 2020, the market is expected to grow at a compound annual growth rate of 5.91 percent.
2. Outpatient spine surgery yields substantial cost savings, thus playing a key role in market growth.
3. Outpatient procedures, including minimally invasive procedures, limit the need for blood transfusions, lower infection risk, reduce hospital stays and yield less pain for patients.
4. The market’s major players include Stryker, Zimmer Biomet, NuVasive, Medtronic and DePuy Synthes.
More healthcare news:
7 things for ASC leaders to know for Monday — June 20, 2016
10 of the best stories on ASC leadership in 2016 so far
3 US infants born with Zika-related defects: 4 takeaways
